Updated Q3 2026 by CT Acquisitions.

How to raise growth capital: the 2026 playbook for LMM operators

If you are trying to figure out how to raise growth capital for a lower-middle-market business doing $10M to $250M in revenue, this guide is written for you and not for a pre-seed startup founder. In 2026, the lower-middle-market operator raising $5M to $75M of primary or secondary equity is competing for attention against an estimated $1.2 trillion of unallocated private-equity dry powder, according to PitchBook, and against roughly 4,067 US single-family offices tracked by J.P. Morgan Private Bank. That is a buyer pool, not a scarcity problem. The scarcity is on the sell side: preparing your business, your data room, and your investor list so the right sponsor writes a term sheet at the multiple you deserve.

What is growth capital and how does raising it actually work?

Growth capital is a minority equity investment, usually $5M to $75M for the LMM segment, that funds product, sales, geographic expansion, or founder liquidity without ceding control. Investors like TA Associates, Summit Partners, and Frontenac buy 15 percent to 40 percent of a profitable, growing business at a negotiated multiple of trailing EBITDA. The founder keeps operating control, the investor gets governance rights, and both share the exit.

Growth capital sits between the two extremes that dominate financial news. On one side is venture capital, which funds unprofitable, pre-revenue-to-Series-B startups burning cash to hit growth milestones. On the other side is leveraged buyout private equity, which acquires control of mature businesses and uses debt to juice returns. Growth equity occupies the middle: the business is already profitable, is already growing, and needs equity capital to accelerate rather than to survive.

In practice a growth-capital round funds one or more of four things. The first is organic growth investment: hiring a sales force, opening geographies, or building new product lines that require capital before the payback period closes. The second is a tuck-in acquisition strategy: buying smaller competitors or adjacencies with a mix of equity and acquisition debt. The third is founder secondary: letting the operator and their co-founders take partial liquidity while still running the business. The fourth is balance-sheet repair, which is really a recap and lives closer to our mezzanine debt for acquisitions guide.

The mechanical steps of a growth-capital raise mirror a sell-side M&A process but with a different endpoint. You engage an advisor, prepare a management presentation and a confidential information memorandum, run a targeted outreach to a curated list of 20 to 40 investors, take management meetings, receive indications of interest, negotiate term sheets, sign an exclusivity letter with the winning bidder, complete confirmatory diligence, and close on a new class of preferred stock. The typical timeline is 4 to 7 months from advisor engagement to wire.

Who typically raises growth capital in the lower middle market?

The typical LMM growth-capital candidate is a founder-owned or founder-plus-partner business with $10M to $250M in revenue, $1M to $25M in EBITDA, 15 percent or better EBITDA margins, and a two-year growth rate above 15 percent. Verticals raising the most 2024-2026 growth capital include vertical SaaS, healthcare services (dental, dermatology, MSO platforms), industrial services, business services, and specialty consumer. Owners are typically 45 to 65 years old and want partial liquidity plus a growth partner rather than a full sale.

The audience for a growth-capital raise is not the Silicon Valley startup founder. It is the operator who built a $30M-revenue commercial HVAC business over 18 years and wants to buy three competitors while taking $8M of chips off the table. It is the second-generation owner of a $75M specialty distributor who wants a growth partner to fund the next geographic expansion. It is the software founder whose bootstrapped SaaS business hit $12M ARR and needs equity to fund a sales team without diluting to a venture round.

Sponsors evaluate these operators against a consistent scorecard. Revenue quality is scored on recurring-revenue mix, gross retention, customer concentration (the top 10 customers producing less than 30 percent of revenue is the usual cutoff), and pricing power. Growth quality is measured on organic growth versus acquired growth, unit economics, and the size of the addressable market. Team quality is measured on the depth of the bench below the founder and whether the CFO can survive institutional diligence.

Where operators disqualify themselves is usually on three fronts. Concentration issues, either customer or supplier, kill more deals than valuation gaps. Weak financial controls make sponsors nervous about what diligence will surface. And an operator unwilling to accept any dilution, board oversight, or preference stack is not actually raising growth capital, they are looking for a bank loan. Our lower-middle-market M&A advisor guide covers the operator profile in more depth.

How does growth capital compare to venture capital, private equity, and debt?

Growth capital differs from venture capital because it requires profitability and buys minority stakes in mature businesses, and differs from buyout private equity because it does not take control or add significant leverage. Compared to senior debt or unitranche, growth capital does not require monthly amortization, does not put personal guarantees at risk, and does not have covenants that trigger in a downturn. The tradeoff is dilution and governance sharing rather than leverage risk.

The table below breaks down the practical differences across the four most common capital sources for an LMM operator. Choose the row that matches your business profile and objectives, not the row that sounds cheapest, because dilution is only one dimension of cost.

Capital source	Business profile	Check size (LMM)	Cost of capital	Control impact
Venture capital	Pre-profit, high growth, tech or biotech	$2M to $50M	Dilution of 15% to 30% per round	Board seats, protective provisions, milestone gates
Growth equity (minority)	Profitable, 15%+ growth, $1M to $25M EBITDA	$5M to $75M	Dilution of 15% to 40%	Minority board seat, protective provisions, no daily involvement
Buyout private equity (control)	Established, stable cash flow, willing to sell 50%+	$25M to $300M+	Full control transfer, rollover equity typical	Board control, CEO reports to board, capital structure reset
Senior debt / unitranche	Steady cash flow, 3.0x to 4.5x leverage tolerable	$5M to $100M+	SOFR plus 500 to 800 bps (2026)	No equity dilution, but covenants and personal guarantees
Mezzanine debt	Steady cash flow with some growth capex	$5M to $50M	10% to 14% cash coupon plus warrants	Board observer typical, no daily involvement

The right answer is almost never a single source. LMM growth capital raises in 2024, 2025, and 2026 have increasingly stacked minority equity with a senior credit facility and sometimes a mezzanine layer to keep dilution below 30 percent while still funding the acquisition or growth plan. Our growth equity vs private equity and debt vs equity financing guides walk through the math on blended cost of capital.

When does raising growth capital make sense versus alternatives?

Growth capital makes sense when the business has more growth opportunity than internal cash flow can fund, when the owner wants partial liquidity without a full sale, or when a strategic acquisition would require more equity than the balance sheet supports. It does not make sense when the growth is speculative rather than proven, when the owner would rather keep 100 percent control, or when senior debt at SOFR plus 500 to 800 basis points would achieve the same result without dilution.

The clearest fit is the operator running a fundamentally sound business who has identified a specific use of capital with a defensible return profile. That could be funding a national sales rollout, buying three regional competitors to build a platform, opening a second manufacturing facility, or accelerating product development. In each case the return on invested capital is projectable, and the growth would either not happen or would happen years later without equity.

The second good fit is the founder facing a life event. A partner buyout, a divorce, a partial estate planning event, or simply a founder who wants to take $10M off the table while still running the company are all appropriate reasons to raise growth capital with founder secondary attached. Our selling to a growth-equity investor guide walks through how the secondary tranche gets structured inside a primary round.

Where growth capital is the wrong tool: when the business is a stable cash-flow machine with no obvious growth reinvestment thesis, senior or mezzanine debt is typically cheaper and less dilutive. When the founder wants to fully exit and retire, a control sale to private equity or a strategic acquirer produces more liquidity. When the business is pre-profit, growth capital investors will pass and the appropriate source is venture capital or a strategic partner. When the capital need is under $3M, the transaction costs of a formal raise exceed the value of the round.

How much does it cost to raise growth capital, in dilution, fees, and time?

The total cost of a growth-capital raise spans three buckets: dilution of 15 percent to 40 percent for the equity, advisor and legal fees of $500K to $2.5M on a $25M raise, and 4 to 7 months of executive time. GF Data pegged the 2024 median LMM EBITDA multiple at 7.4x, so a $10M-EBITDA business raising $25M at a $74M pre-money enterprise value would give up roughly 25 percent equity plus $1.2M to $2M in transaction expenses.

Dilution is a function of valuation and check size, not a fixed number. A $5M raise at a $45M pre-money is roughly 10 percent dilution. A $30M raise at a $70M pre-money is 30 percent dilution. Advisors negotiate the pre-money valuation harder than any other single lever because a 1x multiple improvement on $10M of EBITDA is $10M of enterprise value, which dwarfs any advisor fee.

Cost category	Typical range (2026)	When it hits	How to control it
Advisor retainer	$50K to $150K	Signed on engagement, credited to success fee	Negotiate credit against success fee at 100%
Advisor success fee	3% to 6% of capital raised, tiered	Wire at closing	Tiered Lehman formula caps fee on large rounds
Company-side legal	$250K to $1.2M	Term sheet through closing	Use term-sheet specialists, not general corporate counsel
Accounting / QoE	$75K to $250K	Pre-marketing preparation	Buyer typically pays for confirmatory QoE
Investor legal (reimbursed)	$150K to $600K	Closing wire, reduces net proceeds	Cap in term sheet at $250K or $350K
Dilution	15% to 40% for minority round	Closing	Layer senior or mezz debt to shrink equity check
Executive time	25% to 50% of CEO / CFO time for 4-7 months	Across full process	Rigorous pre-marketing prep compresses live process

The economics improve materially with process discipline. A well-run process with 20 to 40 curated investors produces multiple term sheets, which typically move valuation 0.5x to 1.5x higher than the first indication, and shift preference and secondary economics in the operator’s favor. A bilateral negotiation with one sponsor produces one bid at the low end of a defensible range.

Who provides growth capital to LMM businesses in 2026?

Growth capital for LMM businesses in 2026 comes from four main sources: dedicated growth-equity firms like Summit Partners and TA Associates, LMM private equity funds like Frontenac and Palladium that write minority checks, family offices increasingly deploying direct into LMM operating businesses, and independent sponsors backed by capital-formation vehicles. Each has a distinct check size, hold period, and value-add profile, and the right fit depends more on thesis alignment than on brand recognition.

The table below names specific firms actively investing in LMM growth-capital transactions with public track records through 2024, 2025, and 2026. This is not exhaustive but represents credible starting points for an LMM operator building an investor target list.

Firm	Type	Typical check size	Focus
Summit Partners	Growth equity	$25M to $500M	Software, healthcare, financial technology, consumer
TA Associates	Growth equity + buyout	$50M to $500M	Technology, healthcare, financial services, consumer, business services
Susquehanna Growth Equity	Growth equity	$25M to $150M	Bootstrapped software and information businesses
Frontenac	LMM private equity	$15M to $75M	Consumer, industrial, and services LMM buyouts and growth
Palladium Equity Partners	LMM private equity	$25M to $150M	Consumer, industrial, services with Hispanic-market thesis
PSG Equity	Growth equity	$20M to $200M	Software and technology-enabled services
Mainsail Partners	Growth equity	$15M to $100M	Bootstrapped B2B software
MidOcean Partners	LMM private equity	$40M to $200M	Consumer, business services, industrial
Pritzker Private Capital	Family capital	$100M to $500M	North American manufactured products and services
Cambridge Wilkinson	Placement agent / capital markets	Facilitates $5M to $500M	LMM debt and equity capital raises

Family offices are the fastest-growing source of LMM growth capital. Per Fintrx and Cerulli, US single-family offices control an estimated $5.5 trillion of AUM, and roughly 40 percent are actively investing directly into operating businesses. Named platforms with public direct-investment activity include Waverley Capital (Barry Diller family), Willett Advisors (Michael Bloomberg), Emerson Collective (Laurene Powell Jobs), Waycross Partners, and Icahn Enterprises. Family-office fit is thesis-driven and slower than institutional, but the hold period is 10 to 20 years and the price is often stronger. See our family office vs PE buyer guide for how family capital differs at the negotiation table.

Independent sponsors are a fourth category worth naming. These are experienced dealmakers without a committed fund who identify a specific transaction, then raise capital deal-by-deal from family offices, funds of funds, or high-net-worth investors. Examples include Compass Group Diversified Holdings, Trive Capital independent-sponsor track record, and dozens of solo practitioners networked through Axial and the McGuireWoods independent sponsor conference, which drew an estimated 1,600 attendees in 2025 per the firm’s published summary.

How does the process to raise growth capital actually work, step by step?

A typical LMM growth-capital raise runs 4 to 7 months across 10 discrete steps: advisor engagement, quality of earnings, positioning and materials build, investor list curation, marketing launch, indications of interest, management meetings, term-sheet negotiation, confirmatory diligence, and closing. The prep phase before any investor sees the book determines 60 percent of the outcome, per our observation across 50-plus LMM capital raises.

1. Advisor engagement (week 0). The operator signs an engagement letter with an M&A advisor or placement agent. Retainer typically $50K to $150K, credited fully against success fee. This is the moment to negotiate tail provisions, exclusivity period, and reimbursable expenses.
2. Sell-side quality of earnings (weeks 1 to 6). An independent accounting firm produces a databook proving normalized EBITDA. Costs $75K to $250K. Skipping this step invites a buyer-side QoE that finds $500K of adjustments in the buyer’s favor.
3. Positioning and materials (weeks 3 to 8). The advisor builds the confidential information memorandum, a management presentation, and a financial model. Positioning defines the equity story: category leadership, growth thesis, moat, and use of proceeds.
4. Investor list curation (weeks 4 to 8). 20 to 40 target investors chosen for fit on sector, check size, geography, and stated thesis. Wrong-list processes fail even with strong businesses.
5. Marketing launch (week 8 to 10). Teaser goes to the target list, followed by CIM to interested parties under NDA. Typical response rate is 40 percent to 70 percent of the target list on a well-positioned LMM asset.
6. Indications of interest (weeks 10 to 14). Investors submit non-binding IOIs with valuation range, structure, key diligence questions, and management-meeting requests. This is where the shape of the process becomes visible.
7. Management meetings (weeks 12 to 18). Selected investors meet the management team, tour facilities, and receive expanded diligence. Typically 6 to 12 meetings, one per week.
8. Term sheet negotiation (weeks 16 to 22). Best-and-final term sheets. Negotiation on valuation, preference stack, board rights, protective provisions, secondary, and closing conditions. This is where advisor value peaks.
9. Confirmatory diligence and exclusivity (weeks 20 to 28). Winning bidder signs an exclusivity letter and completes confirmatory financial, legal, commercial, IT, and HR diligence. Legal drafting runs in parallel.
10. Closing (weeks 26 to 30). Executed purchase agreement, funds flow, and capitalization table update. Escrow and reps-and-warranties insurance typically apply.

Two things compress this timeline. The first is having a clean sell-side QoE, a real financial model, and a data room organized before marketing launch. The second is running a genuinely competitive process rather than a bilateral negotiation. Bilateral processes drag because there is no forcing function on the sponsor to move.

What documentation do you need before an investor will engage?

A credible growth-capital raise requires a confidential information memorandum, a three-year historical financial statements audit or review, a five-year financial model with defensible assumptions, a sell-side quality-of-earnings report, a customer and revenue detail file, an org chart with tenure and compensation, and a cap table. Missing any of these signals institutional immaturity, and sponsors either pass or discount the valuation to compensate.

The data room is not paperwork for its own sake. Institutional investors have diligence checklists that run 200 to 400 line items, and their diligence budget for a single deal is $500K to $2M. Every question you cannot answer within 48 hours reduces the sponsor’s conviction and increases the number of representations and warranties they will insist on in the purchase agreement.

• Financial: three years of audited or reviewed financials, trailing twelve months by month, five-year forward model, sell-side QoE, cash and debt schedule, working capital analysis, revenue by customer and by product.
• Commercial: customer contracts, sales pipeline, churn analysis for recurring-revenue businesses, competitive landscape summary, pricing history, unit economics.
• Legal: corporate formation and cap table, material contracts, employment agreements, IP assignments, litigation summary, insurance policies.
• HR: org chart, compensation detail, benefit plans, equity plan documentation, key-person retention analysis.
• Operational: facilities list and leases, IT systems, cybersecurity summary, KPI dashboards, business continuity plan.

What are the tax and legal implications of raising growth capital?

Growth-capital rounds are typically structured as issuances of preferred stock or preferred units, which are non-taxable to the company at issuance. Founder secondary is taxable at long-term capital gains rates, currently 20 percent federal plus the 3.8 percent net investment income tax, plus state tax. If the business is a pass-through LLC or S-corp, the transaction often requires a conversion or a blocker structure to accommodate institutional investors, and this is where founder-friendly tax planning saves millions.

The tax outcomes depend heavily on entity type. A C-corp receiving primary equity has a clean issuance with no immediate tax impact. An LLC or S-corp raising primary equity from an institutional fund almost always requires either a C-corp conversion or a structural workaround, because pension-plan LPs cannot receive unrelated business taxable income. Section 1202 qualified small business stock treatment can produce a federal-tax exclusion up to $10M on the founder’s stock, and the timing of any recapitalization must be modeled against QSBS eligibility.

On the legal side, the operative agreement is a preferred stock purchase agreement or a preferred unit issuance agreement, paired with an amended and restated shareholders agreement. Key provisions to negotiate include the liquidation preference stack (1x non-participating is founder-friendly, participating with a cap is the middle, participating uncapped is aggressive), anti-dilution protection (broad-based weighted average is standard, full-ratchet is punitive), the board composition and observer rights, protective provisions, drag-along and tag-along rights, information rights, and redemption rights if any.

Our what is a term sheet guide breaks down the specific provisions in a growth-equity term sheet with plain-English commentary on what each provision costs the founder.

What are the common deal structures and preferred-stock terms?

The most common growth-capital structure is convertible participating preferred with a 1x liquidation preference, non-participating preferred (founder-friendly), or convertible preferred with a coupon. In 2024-2026 the LMM norm has drifted toward 1x non-participating preferred with a coupon of 6 percent to 8 percent PIK, plus broad-based weighted-average anti-dilution and a minority board seat with standard protective provisions. Full-ratchet anti-dilution, uncapped participation, and majority board control are red flags on a growth round.

Preferred stock is not one instrument. It is a bundle of economic, control, and information rights, and each is negotiable independently. The economic terms determine what the investor receives on an exit relative to common stockholders. The control terms determine who can veto what corporate action. The information terms determine what reporting the company must produce.

• Liquidation preference: 1x non-participating is founder-friendly, 1x participating with a 3x cap is the middle, participating uncapped is aggressive and rare in growth rounds. This provision alone can swing exit economics by 15 percent to 40 percent.
• Dividend / coupon: 0 percent to 8 percent PIK. A cash-pay coupon on a growth-equity investment is unusual and worth pushing back on because it converts equity into quasi-debt.
• Anti-dilution: broad-based weighted average is the standard. Full-ratchet is a red flag. Waivers for stock plans, strategic issuances, and acquisition currency should be built in.
• Board rights: one investor seat plus one independent director agreed by both sides is typical for a minority round. Majority-of-board investor control is a control transaction, not a growth round.
• Protective provisions: investor consent required for material issuances, sale of the company, incurrence of debt above thresholds, changes to the certificate. Consent thresholds below $250K for operating decisions are hostile.
• Drag-along and tag-along: drag-along typically triggered at 50 percent to 66 percent equity approval and forces minority holders to sell in a company sale. Tag-along protects minority in a founder secondary.
• Redemption: right for the investor to force a buyback after 5 to 7 years. This is a debt-like feature and should either be removed or capped at cost plus coupon.
• Information rights: monthly financials, annual audit, board materials. Standard and rarely negotiated.

What are the red flags to avoid in growth-capital term sheets?

The five most common founder-hostile provisions in an LMM growth-capital term sheet are participating preferred without a cap, full-ratchet anti-dilution, protective-provision thresholds below $250K, redemption rights triggering within 5 years, and no-shop clauses longer than 45 days paired with punitive break fees. Any one of these five reduces founder economics by 5 percent to 25 percent of enterprise value at exit. All five together mean the sponsor is trying to buy a control transaction at a minority price.

Beyond the term sheet itself, three process red flags predict a bad partnership. The first is a sponsor that insists on exclusivity before submitting a full term sheet with confirmed committee approval. The second is a sponsor that walks back their initial valuation after receiving diligence access with no material adverse finding disclosed. The third is a sponsor whose diligence questions telegraph a control mindset, asking about CEO succession, exit timing, and management replacements during a minority-round conversation.

Watch out for the “friendly capital” pitch that comes attached to a debt instrument disguised as equity: cash-pay preferred, mandatory redemption at cost plus coupon, and observer rights that convert to full board seats on covenant breach. In our experience, this structure looks attractive on the term sheet and becomes punishing in year three when the growth plan does not hit projection. Structured capital has legitimate uses, covered in our mezzanine debt for acquisitions and unitranche debt for acquisition financing guides, but it should be priced and disclosed as debt-like.

What are the 2024-2026 market dynamics shaping growth-capital rounds?

Three dynamics defined the 2024-2026 growth-capital market: a $1.2 trillion PE dry-powder overhang per PitchBook, a rate environment that peaked in 2024 and eased through 2025 and 2026 supporting multiple stability, and a family-office capital wave with an estimated $5.5 trillion of AUM increasingly deploying direct. GF Data reported a 7.4x median LMM EBITDA multiple in 2024, and Bain & Company’s 2025 Global Private Equity Report flagged an 18 percent year-over-year rebound in deal volume as capital came off the sidelines.

The rate environment matters because leveraged buyouts drive baseline multiples for the LMM segment. When SOFR was above 5 percent through most of 2024, LBO sponsors had less debt capacity for a given equity check, which pressured multiples down. As the Federal Reserve cut rates through late 2024, 2025, and early 2026, LBO debt capacity expanded, and headline LMM multiples recovered from the trough. Growth-equity minority rounds benefit from this rate tailwind because comparable-transaction pricing floats up alongside LBO comps.

The dry-powder overhang creates a paradox. On paper, $1.2 trillion of committed capital chasing deals should compress returns and inflate multiples. In practice, the capital is concentrated in mega-funds that cannot deploy in the LMM segment, so the actual competition for a $20M growth-equity check is far less than the headline number suggests. This is why the LMM segment produces above-average returns in most vintage years, per Cambridge Associates benchmarks.

Metric	2023	2024	2025 (est)	2026 YTD
Median LMM EBITDA multiple (GF Data)	7.1x	7.4x	7.7x	7.9x
US PE dry powder (PitchBook)	$955B	$1.10T	$1.18T	$1.22T
SOFR (year-end)	5.38%	4.33%	3.87%	3.75%
US LMM deal count (Axial index)	Baseline	+8%	+16%	+22%
Median software minority-growth multiple (revenue)	9.5x	10.8x	12.2x	12.5x

Concrete 2024-2026 comps worth naming include the Summit Partners minority growth investment in Klaviyo prior to its September 2023 IPO, TA Associates growth investment in Netsmart (2022 platform recap), PSG Equity minority growth investment in DispatchTrack (2024), Frontenac’s platform building in specialty distribution through 2024-2025, and Susquehanna Growth Equity’s continued deployment in bootstrapped B2B software categories per PR Newswire announcements across 2024 and 2025. Family-office direct investment activity is tracked in the J.P. Morgan 2024 Single Family Office Report and the Fintrx family-office database.

How does CT Acquisitions help you find the right equity partner?

CT Acquisitions runs a curated, competitive growth-capital raise for LMM operators from engagement through wire: sell-side positioning, quality-of-earnings coordination, 20 to 40 investor process, term-sheet negotiation with named term-sheet counsel, and closing management. Our investor network covers named growth-equity funds, single-family offices deploying direct, and structured-capital providers matched to your revenue profile, growth thesis, and post-close role preference. Learn more at our raise capital hub.

Where a generalist banker treats a growth-capital raise as a sell-side lite, we treat it as a distinct product with its own investor universe, its own diligence pattern, and its own negotiation playbook. Our approach starts with the operator’s post-close role, not with the check size. A founder who wants to run the business for another 10 years should not be talking to the same investors as a founder who wants to hand over operations in 24 months.

Our process bakes in three practical differentiators. First, we build the investor list from a segmentation of your business against real 2024-2026 comparable transactions, not from a stale rolodex. Second, we bring a term-sheet specialist counsel into the process at the LOI stage, before the preferred stock provisions get locked in, because most of the value in a growth-capital round is captured or lost in the preferred-stock terms. Third, we manage the confirmatory diligence process aggressively so the exclusivity window does not become a value-erosion window.

For operators comparing an equity raise to a sale, we run both tracks in parallel through the same process, because the same investor list contains buyers of majority control and minority growth alike. Our related guides walk through the adjacent decisions: sell-side M&A advisory for founders considering a full exit, buy-side M&A advisory for operators using growth capital to fund acquisitions, business acquisition loan options when equity is not the only lever, and leveraged buyout acquisition financing for the larger transactions where growth equity meets buyout capital.

In our experience advising LMM operators on how to raise growth capital, the biggest predictor of a successful outcome is not the size of the check or the brand of the sponsor. It is whether the operator ran a genuinely competitive process. Bilateral negotiations produce one bid on the low end of the range and a term sheet drafted entirely by the buyer’s counsel. A curated 20 to 40 investor process produces three to eight term sheets, moves valuation by 0.5x to 1.5x EBITDA, and gives the operator real leverage on preference, board rights, and secondary. The advisor’s job is to create that competition, not to close the deal that walks in the door.

How do you choose the right advisor to raise growth capital?

Choose an advisor based on four criteria: recent LMM growth-capital transactions in your size range, an investor network that includes funds and family offices matched to your sector, a fee structure that aligns advisor incentives with outcome (retainer credited to success, tiered success fee), and a bench that includes term-sheet counsel and QoE providers. Avoid advisors whose deal history is all sell-side control transactions, because growth capital is a different product.

The advisor-selection decision matters more than the sponsor-selection decision, because the advisor determines which sponsors even see the deal. A weak advisor with a stale investor list shows the deal to the wrong 15 funds and produces one lowball term sheet. A strong advisor with a curated 40-investor list produces competitive tension, better economics, and a partnership fit that survives the first hard quarter.

Advisor type	Fit for growth-capital raise	Typical fee range	Watch out for
LMM-focused M&A advisory (like CT Acquisitions)	Strong fit, growth-capital-native	1-3% retainer + 3-6% success	Verify recent growth-equity transactions, not just sell-sides
Bulge-bracket investment bank	Fit only above $75M raise size	$300K+ retainer + 1-2% success	LMM raises get junior team attention
Boutique placement agent	Strong fit for equity-only mandates	1-2% retainer + 2-4% success	Ensure they have M&A depth if a sale option emerges
Business broker	Poor fit for institutional raises	5-12% flat success fee	Institutional investors will not take meetings from broker referrals
DIY / no advisor	Poor fit for raises over $5M	$0 advisor cost, $2M+ opportunity cost	Bilateral negotiations, hostile term sheets, valuation left on the table

Reference-check every advisor with two or three of their recent LMM growth-capital clients. Ask the operator whether the process produced multiple term sheets, whether the advisor negotiated the preferred-stock provisions aggressively, and whether the advisor stayed present through confirmatory diligence and closing rather than delegating to a junior. Ask the same questions of two named sponsors that closed with that advisor recently. The signal is consistent across references or it is not.

What use of proceeds justifies a growth-capital raise?

The strongest use-of-proceeds narratives for a growth-capital raise are funded acquisitions with identified targets, sales-team expansion with defensible unit economics, geographic expansion with market-entry evidence, and product or service line extension with beta customer commitments. Weak narratives include “we are raising a war chest,” “we might do some M&A,” or “we want to be well-capitalized.” Sponsors underwrite a specific plan, not optionality.

Every dollar in the use-of-proceeds line needs an ROIC story. Sponsors will build a five-year model that projects the return on each incremental dollar of invested capital, and if the story is thin, the pre-money valuation gets marked down or the check size gets cut. The sharpest operators walk into the process with a use-of-proceeds table that names specific hires, specific acquisitions, specific geographic expansions, and specific product launches with dollar amounts and expected payback periods.

• Tuck-in acquisitions: named targets in a defined market, with valuation ranges and integration plans. This is the strongest growth story for platform businesses.
• Sales-team hire plan: named seats, ramp assumptions, quota, expected pipeline. Requires customer-acquisition cost history to underwrite.
• Geographic expansion: specific markets, entry economics, competitive analysis, path to profitability by market.
• Product or service line extension: beta customer commitments, unit economics, cannibalization analysis.
• Founder secondary: partial liquidity for founders, sized to keep the founder motivated and in role. Typically 20 percent to 40 percent of the round.
• Balance sheet cleanup: refinancing high-cost debt, paying off shareholder loans, resolving deferred compensation. Usually 5 percent to 15 percent of proceeds if included at all.

How should you think about valuation before signing an engagement letter?

Before signing an advisor engagement letter, model three valuation scenarios: a defensible floor based on comparable 2024-2026 LMM transactions at your growth rate and margin, a defensible target based on premium comps in your subsector, and a stretch case that assumes a strategic bidder joins the process. GF Data’s 2024 median LMM EBITDA multiple was 7.4x, so a $6M-EBITDA business at market would price around $44M enterprise value, and a premium-quality business in a hot subsector could reach $60M to $80M.

Comparable-transaction pricing is the anchor. Public LMM databases like GF Data, PitchBook, Axial, and PE press releases produce enough data points to build a defensible range in almost any sector. Recurring-revenue businesses trade on revenue multiples in the software and vertical SaaS segments (10x to 18x ARR for growth minority rounds per PitchBook 2024 data). Services businesses trade on EBITDA multiples (6x to 10x for growth minority rounds in the LMM range).

What moves your business up or down the range is measurable. Growth rate above 25 percent organic adds 1x to 2x. Recurring revenue above 70 percent of total adds 1x to 2x. Customer concentration with the top 10 above 40 percent of revenue subtracts 0.5x to 1.5x. Gross margins above 60 percent add 1x to 1.5x. A depth-of-management bench that lets the founder step back adds 0.5x to 1x. These are averages, not promises, and each subsector has its own weighting.

What negotiation levers matter most in a growth-capital term sheet?

The five term-sheet levers that produce the most economic value for founders are pre-money valuation, liquidation preference stack, secondary sizing, board composition, and protective-provision thresholds. Over a $50M raise at typical LMM terms, these five levers can swing net founder outcome at exit by 20 percent to 60 percent. Advisors and term-sheet counsel that negotiate all five aggressively earn their fees several times over.

Pre-money valuation is the headline lever and gets 80 percent of the operator’s attention, but the preference stack often moves total founder economics more. A $75M pre-money with 2x participating preferred can produce a worse founder outcome at exit than a $65M pre-money with 1x non-participating. The exit math is where the preference stack shows up, so any term-sheet negotiation without an exit-waterfall model is negotiating blind.

Secondary sizing is the negotiation lever most often left unclaimed. A founder taking $5M off the table in a primary-plus-secondary structure can often push the secondary to $10M to $15M without meaningfully changing the sponsor’s underwriting, especially in a competitive process. Every dollar of secondary at long-term capital gains rates is worth roughly $1.24 pre-tax versus $1.00 of retained equity that faces future dilution and market risk.

Board composition determines who gets veto rights over the next round, over an eventual sale, over the CEO. Protective provisions determine whether the operator can run the business day-to-day without asking permission. Both matter more in year three than at closing, when the honeymoon assumptions get tested. Founder-friendly board and protective-provision terms are worth negotiating hard even when the sponsor pushes back.

What does life look like after closing a growth-capital round?

Post-close life for an LMM operator with a minority growth investor involves quarterly board meetings, monthly reporting, and ongoing dialogue on strategy, hiring, and capital allocation. The best sponsors add real value on M&A pipeline, executive recruiting, and category insight. The worst sponsors add friction on operating decisions. Because the sponsor is minority, the operator retains decision authority on almost everything below the protective-provision thresholds negotiated in the term sheet.

The first 90 days set the pattern. Sponsors typically bring in a value-creation plan built during diligence, which becomes the shared roadmap for the hold period. The operator and sponsor jointly refine the plan, assign responsibility for each initiative, and set the KPI dashboard that will drive board meetings. Founders who treat the first 90 days as an alignment exercise get more value from the partnership than founders who treat it as a compliance exercise.

Reporting cadence is monthly for financials and quarterly for board meetings. Institutional sponsors expect a management-prepared package by the 15th of the following month at the latest, and their portfolio-operations team will critique the format if it does not meet institutional standards. This is why the CFO upgrade often happens in the first 6 to 12 months post-close.

The exit conversation typically starts in year three of a five-to-seven-year hold. Growth-equity sponsors have fund-lifecycle pressure to return capital, so the exit path is a live topic from day one. Family offices are more flexible on timing but still expect a liquidity path over 7 to 12 years. Understanding the sponsor’s fund lifecycle at the time of investment is essential to predicting when the exit conversation gets serious.

What are the alternatives if you cannot raise growth capital right now?

If a growth-capital raise is not the right fit today, the four main alternatives are senior debt or unitranche for capital needs under 4.0x leverage, mezzanine debt for capital needs above senior capacity, an SBA 7(a) loan for smaller acquisitions and expansion needs up to $5M, or a partial sale to a strategic buyer or private equity control acquirer. Each has different economics, control implications, and timelines, and the right answer depends on the specific capital need and the operator’s post-close preferences.

Senior debt is the cheapest capital available to a profitable LMM business, priced in 2026 at SOFR plus 500 to 800 basis points depending on leverage and industry, per Refinitiv LPC quarterly LMM lender surveys. It carries no dilution, no board seat, and no permanent capital-structure change, but it does require monthly cash service, financial covenants, and often personal guarantees on the operator’s side. Suitable for stable cash-flow businesses funding a specific capex or acquisition need within leverage tolerance.

Unitranche debt combines senior and subordinated debt into a single facility from a single lender, simplifying the capital structure at a slightly higher rate (SOFR plus 600 to 950 basis points). Common in acquisition financing for LMM buyouts. Our unitranche debt acquisition financing guide walks through the mechanics.

Mezzanine debt sits below senior in the capital stack, carries a 10 percent to 14 percent cash-plus-PIK coupon, and often includes a warrant to give the mezzanine lender equity upside. Suitable for operators who want to fund growth without material equity dilution and can service the higher coupon. Detailed in our mezzanine debt for acquisitions guide.

SBA 7(a) loans and small-business acquisition loans work for capital needs below $5M, particularly for owner-operator acquisitions. See our business acquisition loan resource. For larger or more complex acquisitions, our leveraged buyout acquisition financing guide covers the stack.

Frequently asked questions

How much growth capital can an LMM business actually raise?

A profitable LMM business with $1M to $25M of EBITDA can typically raise a minority growth round of $5M to $75M priced at 6.0x to 10.5x trailing EBITDA, per GF Data 2024 benchmarks. The number scales with growth rate, gross margin, customer concentration, and category. A 30 percent organic grower with 60 percent gross margins commands a premium multiple to a 10 percent grower at 30 percent margins.

How long does it take to raise growth capital?

Plan for 4 to 7 months from advisor engagement to funded transaction. That splits into roughly 6 to 12 weeks of pre-marketing preparation, 6 to 8 weeks of investor outreach and management meetings, 3 to 4 weeks of term-sheet negotiation and best-and-final, and 6 to 10 weeks of confirmatory diligence, legal drafting, and closing. Aggressive processes run 90 days end to end, but skipping prep costs valuation.

What dilution should I expect from a growth-capital round?

A primary-only minority round typically prices the investor at 15 percent to 40 percent of post-money equity. Founder secondary sits on top, so total ownership handed over often lands between 25 percent and 49 percent. Anything above 50 percent is not a growth round, it is a control transaction. Structure and preference stack matter as much as the headline percentage.

What is the difference between growth equity and private equity?

Growth equity buys a minority stake in a profitable, growing business and rides the ride alongside the founder. Traditional buyout private equity buys control, typically with leverage, and reworks the capital structure. In practice, the line has blurred: firms like TA Associates, Summit Partners, and PSG Equity do both minority growth checks and control buyouts. See our comparison at growth equity vs private equity.

Do I need an investment banker or advisor to raise growth capital?

For any raise above $5M in the LMM segment, an advisor pays for itself through competitive tension, investor list curation, and term-sheet leverage. A DIY raise typically leaves 10 percent to 25 percent of valuation on the table and exposes the founder to hostile terms buried in the preferred stock. Advisor fees are 1 percent to 3 percent retainer plus 3 percent to 6 percent success.

Can I raise growth capital from a family office instead of a PE firm?

Yes, and in 2026 it is often preferable. Family offices accept 10 to 20 year holds, price on a strategic thesis rather than a fund IRR clock, and are more flexible on governance. Per Fintrx and Cerulli, US family offices control an estimated $5.5 trillion of AUM. The tradeoff is slower decision-making and thinner value-add on portfolio operations.

What multiples are LMM growth rounds trading at in 2026?

GF Data reported a 7.4x median EBITDA multiple across LMM transactions in 2024, with growth-oriented minority rounds pricing 1.0x to 2.5x higher for premium platforms. Software and vertical SaaS command 10x to 18x revenue in minority growth rounds, per PitchBook Q4 2024 data. Rate cuts through 2025 and 2026 have supported multiple stability despite a slower LBO market.

What is the biggest mistake operators make when they raise growth capital?

Talking to one sponsor at a time. A bilateral negotiation with a single fund produces one bid, no leverage, and a term sheet drafted entirely by the buyer’s counsel. A curated 20 to 40 investor process produces competitive tension, multiple term sheets, and negotiating room on price, preference, board composition, and secondary. The second-biggest mistake is negotiating the LOI without a term-sheet specialist reviewing preferred-stock provisions.

Related CT Acquisitions resources

Growth-capital decisions rarely stand alone. Adjacent CT resources help operators pressure-test a raise against a sale, a debt-only alternative, or a hybrid stack. Start with the raise-capital hub, then compare across the sell-side and buy-side pillars to see how the same investor universe underwrites minority growth checks, majority buyouts, and acquisition financing on the same LMM operator profile.

• Raise capital hub
• Sell-side M&A advisory
• Buy-side M&A advisory
• Lower-middle-market M&A advisor
• Growth equity vs private equity
• Selling to a growth-equity investor
• Family office vs PE buyer
• What is a term sheet
• Mezzanine debt for acquisitions
• Unitranche debt acquisition financing
• Business acquisition loan
• Leveraged buyout acquisition financing

Sources

• PitchBook Q4 2024 Global Private Market Fundraising Report
• GF Data 2024 Valuation and Leverage Reports
• Axial LMM Investment Banker Benchmarks
• J.P. Morgan 2024 Global Single Family Office Report
• Bain and Company Global Private Equity Report 2025
• McKinsey Private Equity and Principal Investors Insights
• PwC US Private Equity Deals Insights
• Fintrx Family Office Database
• Summit Partners investor page
• TA Associates investor page
• Susquehanna Growth Equity investor page
• PSG Equity investor page
• Frontenac investor page
• Palladium Equity Partners investor page
• PR Newswire deal announcements 2024-2025
• Mainsail Partners investor page
• SEC EDGAR filings for named sponsors and portfolio companies